glucagon like peptide 1 glp 1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Comparing Ozempic, Wegovy and Other
Description
This study included 41 participants (RYGB: n=21, OAGB: n=20) from the randomized RYSA trial with similar amounts of bypassed intestine between the procedures
Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control
GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.
Get started with Hers and gain the confidence you deserve.
Clinical trials are gold standard but they're also controlled, time-limited, and built around statistical averages
